Press Releases
Please view the latest press from Enzo Biochem, Inc.
Date | Details |
Monday December 12, 2022 | Enzo Biochem Reports First Quarter Fiscal Year 2023 Financial Results and Provides Business Update |
Wednesday December 07, 2022 | Enzo Biochem, Inc. to Report First Quarter Fiscal 2023 Financial Results and Business Update on Monday, December 12th |
Tuesday November 08, 2022 | Enzo Biochem, Inc. Announces Date of Annual Shareholders’ Meeting |
Thursday October 20th, 2022 | Enzo Biochem, Inc. Appoints Patricia Eckert, CPA as Interim CFO |
Friday October 14, 2022 | Enzo Biochem Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Provides Business Update |
Monday October 10th, 2022 | Enzo Biochem to Report Fourth Quarter 2022 Financial Results and Business Update on Friday, October 14th |
Thursday October 6th, 2022 | Enzo Biochem, Inc. Opens Expanded Life Sciences Laboratory and Office Facilities in Farmingdale, New York |
Monday, September 26, 2022 | Enzo Biochem, Inc. Launches AMPIVIEW™ Gene Expression Platform with First Products Targeting Detection of HPV and SARS-CoV-2 |
Thursday, August 11th, 2022 | Enzo Biochem to Launch Monkeypox Testing Services this Week |
Wednesday, August 3rd, 2022 | Enzo Biochem Appoints Matthew Kupferberg as General Counsel |
Thursday, June 9th, 2022 | Enzo Biochem Reports Third Quarter Fiscal 2022 Results and Provides Leadership and Corporate Updates Including Engagement of Jefferies as Financial Advisor |
Monday, June 6th, 2022 | UPDATE -- Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th |
Thursday, June 2nd, 2022 | Enzo Biochem to Report Third Quarter 2022 Financial Results and Business Update on Thursday, June 9th |
Tuesday, April 19, 2022 | Enzo Biochem Announces New York State Department of Health Approval of HPV Molecular Diagnostic Test |
Tuesday April 12, 2022 | Enzo Biochem Reports Results of its Annual Meeting of Shareholders |
Friday April 01, 2022 | Enzo Biochem Adjourns Annual Meeting of Shareholders Until April 8, 2022 |
Wednesday April 06, 2022 | Enzo Biochem Adjourns Annual Meeting of Shareholders to Complete Vote on Proposal |
Tuesday March 28, 2022 | Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions |
Monday March 14, 2022 | Enzo Biochem Reports Second Quarter Fiscal 2022 Result and Provides Leadership and Corporate Updates |
Thursday March 10, 2022 | Enzo Biochem to Present at the KeyBanc Capital Markets' Life Sciences & MedTech Investor Forum |
Tuesday March 08, 2022 | Enzo Biochem to Report Second Quarter 2022 Financial Results and Business Update on Monday, March 14th |
Monday January 03, 2022 | Hamid Erfanian and Bradley Radoff Appointed to Enzo Biochem’s Board of Directors |